Neurelis, Inc.

San Diego,  CA 
United States
  • Booth: 1029

Neurelis, Inc. is an innovation-driven neuroscience company focused on the development and commercialization of product candidates and innovative delivery technologies for the broader central nervous system (CNS), including epilepsy and psychiatry. In 2020, Neurelis reached a milestone in patient care with its first FDA-approved treatment.

For Technical Support with this webpage, please contact support.